Inventor

Albertus Dominicus Marcellinus Erasmus Osterhaus

Inventor
Antwerp, BE

Overview

19→
Patents
2003–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes16%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
C07KPeptides15%
C12NMicroorganisms or enzymes15%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms15%
G01NInvestigating or analysing materials by determining their chemical or physical properties15%
Y02ATechnologies for adaptation to climate change5%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
A23VIndexing scheme relating to foods, foodstuffs or non-alcoholic beverages and lactic or propionic acid bacteria used in foodstuffs or food preparation2%
C12YEnzymes1%
PatentTitleYear
10,781,426Human Betacoronavirus lineage C and identification of N-terminal dipeptidyl peptidase as its virus receptor202010,519,517Virus causing respiratory tract illness in susceptible mammals201910,287,640Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences201910,167,524Virus causing respiratory tract illness in susceptible mammals20199,944,997Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences20189,834,824None20179,803,252'Virus causing respiratory tract illness in susceptible mammals'20179,593,386'Virus causing respiratory tract illness in susceptible mammals'20179,567,653'Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences'20179,376,726'Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences'20169,334,543'Virus causing respiratory tract illness in susceptible mammals'20168,927,206'Virus causing respiratory tract illness in susceptible mammals'20158,841,433'Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences'20148,722,341'Metapneumovirus strains and their use in vaccine formulations and sequences'20148,715,922'Virus causing respiratory tract illness in susceptible mammals'20147,531,342'Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences'20097,449,324'Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences'20087,288,271'Chlorogenic acid and an analog thereof for immune system stimulation'20076,632,459'Chlorogenic acid and an analog thereof for immune system stimulation'2003

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2003–2019Based in Bunnik, NL· patent location history
2008–2019Patents assigned to VIRONOVATIVE BV (6)· patent assignee history
2008–2019Based in Antwerp, BE· patent location history
2014–2015Patents assigned to FOUCHIER RONALDUS ADRIANUS MARIA (4)· patent assignee history
2014–2015Patents assigned to OSTERHAUS ALBERTUS DOMINICUS MARCELLINUS ERASMUS (4)· patent assignee history
2014–2015Patents assigned to VAN DEN HOOGEN BERNADETTA GERARDA (4)· patent assignee history
2017–2020Patents assigned to UNIV ERASMUS MED CT ROTTERDAM (9)· patent assignee history
2017Based in Antwerpen, BE· patent location history
2020Based in Rotterdam, NL· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
UNIV ERASMUS MED CT ROTTERDAM92017–2020
VIRONOVATIVE BV62008–2019
FOUCHIER RONALDUS ADRIANUS MARIA42014–2015
OSTERHAUS ALBERTUS DOMINICUS MARCELLINUS ERASMUSself42014–2015
VAN DEN HOOGEN BERNADETTA GERARDA42014–2015
Locations
LocationPatentsSpan
Antwerp, BE92008–2019
Bunnik, NL72003–2019
Antwerpen, BE22017
Rotterdam, NL12020